1. Home
  2. CSTE vs XGN Comparison

CSTE vs XGN Comparison

Compare CSTE & XGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CSTE

Caesarstone Ltd.

HOLD

Current Price

$1.78

Market Cap

66.7M

Sector

Industrials

ML Signal

HOLD

Logo Exagen Inc.

XGN

Exagen Inc.

HOLD

Current Price

$4.48

Market Cap

71.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CSTE
XGN
Founded
1987
2002
Country
Israel
United States
Employees
N/A
N/A
Industry
Building Materials
Medical Specialities
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
66.7M
71.2M
IPO Year
2012
2014

Fundamental Metrics

Financial Performance
Metric
CSTE
XGN
Price
$1.78
$4.48
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
$8.86
AVG Volume (30 Days)
163.0K
409.1K
Earning Date
05-13-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$3.43
$8.12
Revenue Next Year
$2.83
$13.00
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.56
$2.59
52 Week High
$2.58
$12.23

Technical Indicators

Market Signals
Indicator
CSTE
XGN
Relative Strength Index (RSI) 53.76 54.82
Support Level $1.42 $2.68
Resistance Level $1.76 $5.55
Average True Range (ATR) 0.12 0.41
MACD -0.02 -0.09
Stochastic Oscillator 19.74 22.10

Price Performance

Historical Comparison
CSTE
XGN

About CSTE Caesarstone Ltd.

Caesarstone Ltd manufactures engineered quartz surfaces. Its products include engineered quartz and porcelain slabs, which are used as kitchen countertops in renovation and remodeling, and residential construction. It also has other applications, including vanity tops, wall panels, backsplashes, floor tiles, stairs, and other interior surfaces that are used in various residential and non-residential applications. The company sells its products under the Caesarstone brand. Caesarstone's geographical segments are the United States, Canada, Latin America, Australia, Asia, Israel, and EMEA(Europe, Middle East, Africa), of which it derives maximum revenue from United States.

About XGN Exagen Inc.

Exagen Inc is a medical technology company focused on the design, development and commercialization of diagnostic testing products under its AVISE brand. These products are used for the differential diagnosis, prognosis, and monitoring of rheumatic, autoimmune, and related diseases, including systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). The company operates in one operating segment. The majority of the company's revenue is derived from sales of its testing products.

Share on Social Networks: